| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 5 | +60.00% | -1.29% | +0.24% | -1.54% | -0.68% | — |
| 14d | 5 | +80.00% | -4.08% | +0.58% | -4.66% | -3.42% | — |
| 30d | 5 | +60.00% | +7.17% | -1.08% | +8.25% | -0.73% | — |
| 60d | 5 | +60.00% | -8.81% | -4.44% | -4.37% | -1.57% | — |
| 90d | 5 | +60.00% | -11.66% | -1.47% | -10.19% | -2.31% | — |
| 180d | 5 | +80.00% | -8.24% | +8.27% | -16.51% | -19.32% | — |
| 1y | 5 | +20.00% | +49.12% | +18.86% | +30.26% | +53.18% | — |
| 2y | 5(2 pending) | +0.00% | +145.64% | +44.30% | +101.34% | +157.19% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 7,394 | — | — | 7,394 | Jun 17, 2026 | Jun 22, 2026 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | SALE EVP, Chief Commercial Officer | 874 | $29.86 | $26.1K | 61,996 | Jun 1, 2026 | Jun 3, 2026 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 19,430 | — | — | 62,870 | Feb 17, 2026 | Feb 19, 2026 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | SALE EVP, Chief Commercial Officer | 3,546 | $34.62 | $122.8K | 43,440 | Feb 10, 2026 | Feb 12, 2026 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | SALE EVP, Chief Commercial Officer | 5,718 | $36.01 | $205.9K | 46,986 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 7,394 | — | — | 7,394 | Sep 15, 2025 | Sep 17, 2025 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 7,850 | — | — | 7,850 | Mar 17, 2025 | Mar 19, 2025 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 6,875 | — | — | 6,875 | Mar 17, 2025 | Mar 19, 2025 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | SALE EVP, Chief Commercial Officer | 1,796 | $21.93 | $39.4K | 51,704 | Feb 5, 2025 | Feb 6, 2025 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | SALE EVP, Chief Commercial Officer | 2,125 | $20.92 | $44.5K | 53,500 | Feb 4, 2025 | Feb 6, 2025 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 19,717 | — | — | 55,625 | Jan 29, 2025 | Jan 31, 2025 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 14,788 | — | — | 14,788 | Jan 29, 2025 | Jan 31, 2025 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 8,000 | — | — | 8,000 | Nov 25, 2024 | Nov 26, 2024 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 78,500 | — | — | 78,500 | Feb 28, 2024 | Mar 1, 2024 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Feb 28, 2024 | Mar 1, 2024 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | SALE EVP, Chief Commercial Officer | 8,918 | $1.14 | $10.2K | 349,093 | Feb 5, 2024 | Feb 6, 2024 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | SALE EVP, Chief Commercial Officer | 5,601 | $1.13 | $6.3K | 358,011 | Feb 2, 2024 | Feb 6, 2024 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 157,000 | — | — | 157,000 | Jan 23, 2024 | Jan 25, 2024 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 209,000 | — | — | 363,612 | Jan 23, 2024 | Jan 25, 2024 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | SALE EVP, Chief Commercial Officer | 5,388 | $1.66 | $8.9K | 144,612 | Feb 2, 2023 | Feb 6, 2023 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 160,000 | — | — | 160,000 | Jan 26, 2023 | Jan 30, 2023 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 50,000 | — | — | 100,000 | Jan 26, 2023 | Jan 30, 2023 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 80,000 | — | — | 150,000 | Jan 26, 2023 | Jan 30, 2023 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | Dec 28, 2022 | Dec 30, 2022 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 50,000 | — | — | 60,000 | Jan 24, 2022 | Jan 26, 2022 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Jan 24, 2022 | Jan 26, 2022 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 137,500 | — | — | 137,500 | Jan 27, 2021 | Jan 28, 2021 ↗ | View → |
| RIGL RIGEL PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Aug 19, 2020 | Aug 20, 2020 ↗ | View → |